DMT, a natural component of ayahuasca tea promotes neurogenesis, a new study reports. Researchers found DMT was capable of activating neural stem cells and promoted the formation of new neurons.
DMT alters electrical activity in the brain. The compound significantly decreases alpha wave activity, the dominant rhythm associated with wakefulness, and increases theta waves, associated with dreaming. Overall brain activity becomes more chaotic and less predictable. The findings advance the understanding of the neurobiological underpinnings of immersive states of consciousness.
DMT, an active compound of the psychedelic Ayahuasca, is naturally occurring in the mammalian brain, researchers have discovered. The study revealed DMT levels increased significantly in the rat visual cortex following cardiac arrest.
Research on rats suggests microdosing DMT may have beneficial effects for those suffering depression and anxiety, but also probable adverse changes in neuronal structures and metabolism.
Researchers consider the neurobiology of near death experiences.
Researchers report DMT, the psychoactive compound of ayahuasca, can mimic actual near death experiences in healthy subjects.
Ayahuasca, a psychedelic drink made from Amazonian plants, may help relieve symptoms in those with treatment resistant depression, researchers report.
A new study reveals psychedelics increase dendrites, dendritic spines and synapses, while ketamine may promote neuroplasticity. The findings could help develop new treatments for anxiety, depression and other related disorders.
Men who have prior experience with psychedelic drugs have a reduced likelihood of engaging in violence against their partner, a new study reports.
A new study reveals psychedelic substances may have a neuroprotective role when it comes to inflammation. Researchers also report psychedelics can alter signaling pathways associated with neuroplasticity.
According to a new study, psychedelics show some success in treating some psychological disorders.
According to a new study, women who exclusively breastfed their infants for at least two months postpartum had a lower risk for multiple sclerosis returning for six months after birth.
